Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raltitrexed-Cisplatin Induction and Concurrent Chemoradiotherapy in NPC
NCT02562599Phase 2Completed
- Sponsor
- Hubei Cancer Hospital
- Start
- Aug 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of raltitrexed in nasopharyngeal carcinoma (NPC), sponsored by Hubei Cancer Hospital. Started Aug 2015; status: completed.
02
Drugs
raltitrexed
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT02562599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02562599.